BioForm Medical and Galderma Laboratories Chiefs to offer their perspectives on aesthetics market at ODAC conference

20. November 2009 05:08

The Orlando Dermatology Aesthetic & Clinical (ODAC) conference is proud to welcome two leading executive officers offering their unique perspectives on the state of the industry and future opportunities at its 7th annual program, being held on January 15, 2010 at The Peabody Orlando in Orlando, Florida. [More]

3efde888-8df2-4e00-b41b-d738b90ceb88|0|.0

Posted in: Pharmaceutical News

Tags: Dermatology, Education

U.S. Patent Office approves multiple patent claims from Helix BioMedix

20. November 2009 02:14

Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced the United States Patent and Trademark Office has allowed multiple claims in one of the company’s recent patent applications. US patent application 12/005653, “Short Bioactive Peptides for Cellular and Immunological Modulation,” covers a number of peptides including Heptapeptide-7, a SmartPeptides™ technology and lead component in the Striking™ Skin Care line. The patent is expected to issue shortly. [More]

7112d9bd-18c1-4305-8554-d9ce54fb4d7a|0|.0

Posted in: Medical Patent News

Tags: Acne, Dermatology, Wound Healing

New non-surgical procedure to improve body contours

19. November 2009 23:35

The University of Alabama at Birmingham (UAB) Department of Dermatology is offering a new non-surgical, needle-free skin-tightening procedure that doctors say smoothes wrinkles, firms up baggy or loose skin and improves body contours. [More]

08a970a1-ab0c-41d4-be2a-6f1a22dad3d3|0|.0

Posted in: Medical Procedure News

Tags: Collagen, Dermatology

Anika Therapeutics' "ELEVESS Light" receives European CE Mark approval

19. November 2009 09:27

Anika Therapeutics, Inc., a leader in products for tissue protection, healing and repair based on hyaluronic acid (“HA”) technology, today announced that it has received European CE Mark approval for “ELEVESS™ Light,” the Company’s latest aesthetic product used for the treatment of fine lines and facial wrinkles. ELEVESS Light will be distributed in the European market by the Company’s current aesthetic dermatology distributors. [More]

483f6ef3-396e-4198-bf46-5f5725cd0e4a|0|.0

Posted in: Device / Technology News

Tags: Dermatology, Facial Wrinkles, Osteoarthritis

Intensive refresher course in pediatrics for physicians preparing for certification examination

19. November 2009 06:55

Research and Markets (http://www.researchandmarkets.com/research/d3e55b/pediatric_board_re) has announced the addition of the "Pediatric Board Review" report to their offering. [More]

d4ec9abc-91de-438c-89da-9ba0d7241de0|0|.0

Posted in: Child Health News

Tags: Allergy, Autism, Biochemistry, Cardiology, Dermatology, Education, Endocrinology, Gastroenterology, Genetics, Hematology, Hospital, Immunology, Learning Disability, Metabolism, Nephrology, Neurology, Nutrition, Obstetrics, Oncology, Ophthalmology, Orthopedic, Pediatrics, Psychiatry, Radiology, Rheumatology, Sports Medicine

Xeomin receives approval for post-stroke spasticity of upper limb in European countries

19. November 2009 01:42

Today, Merz Pharmaceuticals announced Xeomin®, the first botulinum toxin type A free from complexing proteins has been granted an extension of indication for post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults in various European countries. [More]

234d5eb2-35a6-4162-8012-1ce935422d94|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Acne, Alzheimer's Disease, Dermatology, Diarrhea, Dystonia, Headache, Hygiene, Hypercholesterolemia, Hyperglycemia, Neurology, Parkinson's Disease, Podiatry, Stroke, Tinnitus

Lee's Pharmaceutical granted exclusive license to Jennerex' lead product for HCC

18. November 2009 09:34

Jennerex, Inc., a clinical-stage biotherapeutics company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced in conjunction with Lee's Pharmaceutical Holdings, the execution of a collaboration and license agreement for Jennerex's lead product candidate, JX-594, in certain Asian territories. [More]

4a755256-198d-4b0f-bab9-4a7f9cd7ec29|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Cancer, Cell, Colorectal Cancer, Dermatology, Hepatocellular Carcinoma, Hospital, Liver Cancer, Oncology, Virus

Ambrisentan improves health and exercise capacity of PAH patients, find researchers

18. November 2009 05:24

In one of the few studies of the long-term effects of medication in the treatment of pulmonary arterial hypertension (PAH) disease, a team of researchers found the health and exercise capacity of PAH patients improved after two years of treatment with ambrisentan, according to a study published in the current edition of the Journal of the American College of Cardiology. [More]

59d71bca-2ccd-46b4-b9ff-58d2ca649bb9|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Cancer, Cardiology, Cardiovascular Disease, Dermatology, Diabetes, Exercise, Immunization, Kidney Disease, Nutrition, Pulmonary Arterial Hypertension, Vaccine

Press conference highlights emerging treatments in pancreatic cancer

18. November 2009 03:30

As part of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Thompson will moderate a press conference on emerging treatments in pancreatic cancer on Tuesday, Nov. 17, 2009, in Room 202 of the Hynes Convention Center in Boston, Mass., from 1:00 p.m. to 2:00 p.m. ET. [More]

a8f28545-1bf2-426a-9fe3-eefc360e22ae|0|.0

Posted in: Medical Condition News

Tags: Abraxane, Angiogenesis, Antibody, Avastin, Bevacizumab, Blood Vessel, Cancer, Cell, Chemotherapy, Dermatology, Gemcitabine, Gemzar, Gene Expression, Hospital, Liver Cancer, Metastasis, microRNA, Nanotechnology, Oncology, Paclitaxel, Pancreatic Cancer, Pathology, Photodynamic Therapy, Radiotherapy, VEGF

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

17. November 2009 08:04

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany. [More]

1e4e8117-84c9-490f-b3e0-d09c1aace944|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Apoptosis, Atopic Dermatitis, Breast Cancer, Cancer, Cell, Dermatitis, Dermatology, Evolution, Liver Cancer, Melanoma, Metastasis, Oncology, Psoriasis, Skin Cancer

First phase of new electronic health record system launched at Trinity Center

17. November 2009 06:38

NYU Langone Medical Center launched the first phase of its new electronic health record system last week at their multi-disciplinary faculty group practice at Trinity Center in lower Manhattan. The integrated system, powered by software from Epic Systems Corporation, provides a single platform from which physicians, staff and patients themselves can access and manage medical information. [More]

a0b4b720-4b90-4fba-ae31-d2f2329621b2|0|.0

Posted in: Device / Technology News

Tags: Cancer, Cardiology, Dermatology, Education, Electronic Health Record, Gastroenterology, Hospital, Radiology, Sports Medicine

PsoriasisDX to present seminar on Genetic Screening for Psoriatic Arthritis

17. November 2009 04:14

A seminar on Genetic Screening for Psoriatic Arthritis will be presented on Tuesday, December 8 from 12-1 PM Pacific Standard Time, hosted by pharmacogenomics research and development innovators PsoriasisDX, pioneers of the world’s first genetic test for psoriatic arthritis (PsA). The seminar will feature leading experts Dr. John Koo and Dr. Wilson Liao. [More]

9d0dce3f-560f-4f06-b928-e54455928b6b|0|.0

Posted in: Medical Condition News

Tags: Alopecia, Arthritis, Baldness, Dermatology, Genetics, Inflammatory Disease, Pharmacogenomics, Psoriasis, Psoriatic Arthritis

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

16. November 2009 10:43

Sciele Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd. and Addrenex Pharmaceuticals, Inc., a privately-held U.S. pharmaceutical company specializing in developing drugs that regulate the adrenergic system, today announced that Sciele has agreed to acquire Addrenex. [More]

79e82316-5308-4bc8-b395-d7e3b3286ce9|0|.0

Posted in: Business / Finance

Tags: Allergy, Angina, Asthma, Cancer, Cholesterol, Dermatology, Diabetes, New Drug Application, Pediatrics, Type 2 Diabetes

PhotoMedex to host free seminar to fight against psoriasis with XTRAC Excimer Lasers

16. November 2009 07:15

PhotoMedex, Inc. a leading provider of advanced dermatology, clinical skincare and medical laser products, is hosting a free seminar in Indianapolis, IN on November 17, 2009. [More]

0bbcba01-c280-480d-8755-1b40a56e9681|0|.0

Posted in: Device / Technology News | Medical Condition News

Tags: Acne, Atopic Dermatitis, Cancer, Copper, Dermatitis, Dermatology, DNA, Medicare, Psoriasis, Vitiligo

Ginger effective in treating post-chemo nausea in cancer patients

16. November 2009 06:04

Reed's, Inc., maker of the top-selling sodas in natural food stores nationwide, announced today that it will be exhibiting at the Chemotherapy Foundation Symposium XXVII New Perspectives in Oncology Practice Seminar, Saturday November 14th, at the Marriott Marquis in New York, NY. [More]

d52ab2d7-6590-4c74-b100-eaed414bb881|0|.0

Posted in: Medical Research News | Medical Condition News

Tags: Cancer, Chemotherapy, Dermatology, Ginger, Morning Sickness, Nausea, Oncology, Vomiting

Free!

Recent Comments

Twitter

Information

Dermatology News and Research